BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35398502)

  • 1. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
    Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
    J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
    Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
    J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
    Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
    J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Wogonoside in acute myocardial ischemia rats.
    Feng W; Duan C; Pan F; Yan C; Dong H; Wang X; Zhang J
    J Ethnopharmacol; 2023 Dec; 317():116871. PubMed ID: 37393028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated serum metabolomics and network pharmacology analysis on the bioactive metabolites and mechanism exploration of Bufei huoxue capsule on chronic obstructive pulmonary disease rats.
    Ren H; Wu W; Chen J; Li Q; Wang H; Qian D; Guo S; Duan JA
    J Ethnopharmacol; 2024 Apr; 324():117816. PubMed ID: 38286154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression.
    Li X; Qin XM; Tian JS; Gao XX; Du GH; Zhou YZ
    J Ethnopharmacol; 2021 Jan; 264():113281. PubMed ID: 32810624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated metabolomics and network pharmacology approach to exploring the potential mechanism of tianxiang capsule for treating motion sickness.
    Zhang W; Cao Y; Chen S; Li F; Chen X; Liu Y
    J Ethnopharmacol; 2021 Jul; 275():114107. PubMed ID: 33845144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Brain Metabolomics and Network Pharmacology Analysis to Reveal the Improvement Effect of Bai Chan Ting on Parkinson's Disease.
    Zhang N; Fu J; Gao X; Lu F; Lu Y; Liu S
    Biomed Res Int; 2022; 2022():6113093. PubMed ID: 36523484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction.
    Chu H; Zhang W; Tan Y; Diao Z; Li P; Wu Y; Xie L; Sun J; Yang K; Li P; Xie C; Li P; Hua Q; Xu X
    J Ethnopharmacol; 2023 Dec; 317():116665. PubMed ID: 37279813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.
    He B; Chen Z; Nie Y; Luo M; Xu S; Yan J; Chen Z
    J Immunol Res; 2022; 2022():6588144. PubMed ID: 35733920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activities and mechanisms of intestinal microbiota metabolites of TCM herbal ingredients could be illustrated by a strategy integrating spectrum-effects, network pharmacology, metabolomics and molecular docking analysis: Platycodin D as an example.
    Zhong YH; Liang J; Qin Q; Wang YJ; Peng YM; Zhang T; Liu FY; Zhang XY; He JW; Zhang SW; Zhong GY; Huang HL; Zeng JX
    Phytomedicine; 2023 Jul; 115():154831. PubMed ID: 37094423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of pharmacodynamics, network pharmacology and metabolomics to elucidate effect and mechanism of Artemisia capillaris Thunb. in the treatment of jaundice.
    Yang Q; Wu X; Pan Z; Guan R; Yang P; Liu Y; Yang X; Du W; Liang J; Hu J; Cai W; Ma G
    J Ethnopharmacol; 2023 Mar; 303():115943. PubMed ID: 36414211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Compatibility mechanism of Trichosanthis Fructus-Allii Macrostemonis Bulbus combination against atherosclerosis: based on metabolomics and network pharmacology].
    Li JH; Xu PB; Zhong H; Zhou A; Wu HF; Dai M
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6207-6216. PubMed ID: 36471946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation.
    Liu YM; Li XQ; Zhang XR; Chen YY; Liu YP; Zhang HQ; Chen Y
    J Ethnopharmacol; 2023 Dec; 317():116765. PubMed ID: 37328080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated approach for identifying the efficacy and potential mechanisms of TCM against atherosclerosis-Wu-Zhu-Yu decoction as a case study.
    Li C; Chi C; Li W; Li Z; Wang X; Wang M; Zhang L; Lu J; Liu R
    J Ethnopharmacol; 2022 Oct; 296():115436. PubMed ID: 35667584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
    Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
    J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.